These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2863631)

  • 1. Effects of suramin on HTLV-III/LAV infection presenting as Kaposi's sarcoma or AIDS-related complex: clinical pharmacology and suppression of virus replication in vivo.
    Broder S; Yarchoan R; Collins JM; Lane HC; Markham PD; Klecker RW; Redfield RR; Mitsuya H; Hoth DF; Gelmann E
    Lancet; 1985 Sep; 2(8456):627-30. PubMed ID: 2863631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of the discovery of HTLV-III for the treatment of AIDS.
    Yarchoan R; Mitsuya H; Matsushita S; Broder S
    Cancer Res; 1985 Sep; 45(9 Suppl):4685s-4688s. PubMed ID: 2410113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of suramin in patients with HTLV-III/LAV infection.
    Collins JM; Klecker RW; Yarchoan R; Lane HC; Fauci AS; Redfield RR; Broder S; Myers CE
    J Clin Pharmacol; 1986 Jan; 26(1):22-6. PubMed ID: 3005375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of response to suramin in patients with AIDS and AIDS-related complex.
    Kaplan LD; Wolfe PR; Volberding PA; Feorino P; Levy JA; Abrams DI; Kiprov D; Wong R; Kaufman L; Gottlieb MS
    Am J Med; 1987 Mar; 82(3 Spec No):615-20. PubMed ID: 3548350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex.
    Yarchoan R; Klecker RW; Weinhold KJ; Markham PD; Lyerly HK; Durack DT; Gelmann E; Lehrman SN; Blum RM; Barry DW
    Lancet; 1986 Mar; 1(8481):575-80. PubMed ID: 2869302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T-cell lymphotropic virus (HTLV-III)/lymphadenopathy-associated virus (LAV).
    Balzarini J; Mitsuya H; De Clercq E; Broder S
    Int J Cancer; 1986 Mar; 37(3):451-7. PubMed ID: 2419266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suramin antiviral therapy in the acquired immunodeficiency syndrome. Clinical, immunological, and virologic results.
    Levine AM; Gill PS; Cohen J; Hawkins JG; Formenti SC; Aguilar S; Meyer PR; Krailo M; Parker J; Rasheed S
    Ann Intern Med; 1986 Jul; 105(1):32-7. PubMed ID: 2424353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suramin in the treatment of AIDS: mechanism of action.
    De Clercq E
    Antiviral Res; 1987 Jan; 7(1):1-10. PubMed ID: 2432836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphadenopathic type of Kaposi's sarcoma in a Ugandan child seropositive for LAV/HTLV-III antibodies.
    Marquart KH; Müller HA; Hartter P; Oku JC; Ayuko WO
    J Trop Med Hyg; 1987 Apr; 90(2):93-4. PubMed ID: 3470530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suramin therapy in AIDS and related disorders. Report of the US Suramin Working Group.
    Cheson BD; Levine AM; Mildvan D; Kaplan LD; Wolfe P; Rios A; Groopman JE; Gill P; Volberding PA; Poiesz BJ
    JAMA; 1987 Sep; 258(10):1347-51. PubMed ID: 3650339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Kaposi sarcoma in acquired immune deficiency syndrome (AIDS). I: Clinical findings and laboratory diagnosis].
    Weidauer H; Hofmann H
    Laryngol Rhinol Otol (Stuttg); 1985 Aug; 64(8):418-22. PubMed ID: 2995739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of T cells against infectivity and cytopathic effect of HTLV-III in vitro.
    Mitsuya H; Matsushita S; Yarchoan R; Broder S
    Princess Takamatsu Symp; 1984; 15():277-88. PubMed ID: 6085846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HTLV-III serology distinguishes atypical and endemic Kaposi's sarcoma in Africa.
    Bayley AC; Downing RG; Cheingsong-Popov R; Tedder RS; Dalgleish AG; Weiss RA
    Lancet; 1985 Feb; 1(8425):359-61. PubMed ID: 2857417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Autopsy findings in patients with acquired immunodeficiency syndrome].
    Niedobitek G; Jautzke G; Schwenk J; Krämer A; Sommer D; Metelmann C; Habermehl KO; Stein H
    Zentralbl Allg Pathol; 1986; 132(4):313-23. PubMed ID: 3026119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. African Kaposi's sarcoma and AIDS.
    Downing RG; Eglin RP; Bayley AC
    Lancet; 1984 Mar; 1(8375):478-80. PubMed ID: 6142209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro suppression of HTLV-III/LAV infectivity by a combination of acyclovir and suramin.
    Resnick L; Markham PD; Veren K; Salahuddin SZ; Gallo RC
    J Infect Dis; 1986 Dec; 154(6):1027-30. PubMed ID: 3640792
    [No Abstract]   [Full Text] [Related]  

  • 17. In search of specific inhibitors of retrovirus replication.
    De Clercq E; Balzarini J
    Antiviral Res; 1985; Suppl 1():89-94. PubMed ID: 2417552
    [No Abstract]   [Full Text] [Related]  

  • 18. HHV-8 DNA replication correlates with the clinical status in AIDS-related Kaposi's sarcoma.
    Broccolo F; Tassan Din C; Viganò MG; Rutigliano T; Esposito S; Lusso P; Tambussi G; Malnati MS
    J Clin Virol; 2016 May; 78():47-52. PubMed ID: 26985593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTLV-III.
    Mitsuya H; Popovic M; Yarchoan R; Matsushita S; Gallo RC; Broder S
    Science; 1984 Oct; 226(4671):172-4. PubMed ID: 6091268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaposi's sarcoma in acquired immune deficiency syndrome (AIDS).
    Francis ND; Parkin JM; Weber J; Boylston AW
    J Clin Pathol; 1986 May; 39(5):469-74. PubMed ID: 3722400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.